10-Q: Limitless X Holdings Reports Q1 2025 Results, Impacted by Strategic Shifts and Debt Conversions
Quarterly Report
Limitless X Holdings' Q1 2025 results reveal a significant net loss due to strategic marketing changes and substantial losses from debt settlement.
Summary
- Limitless X Holdings reported its Q1 2025 financial results, showing a net loss of $34.6 million compared to a net loss of $1.08 million in Q1 2024.
- Product sales decreased significantly to $251,936 from $1,022,525 in the same period last year, attributed to changes in marketing strategies.
- Operating expenses increased substantially to $4.37 million, primarily due to higher stock compensation expenses.
- The company recognized a loss on debt settlement of $29.9 million due to the conversion of loans payable to shareholders into preferred stock.
- As of March 31, 2025, the company's accumulated deficit stood at $73.5 million.
- The company's cash balance decreased to $39,491 from $53,549 at the end of 2024.
- The company is focusing on health products and digital marketing services.
- The company had a material weakness in internal control over financial reporting due to insufficient personnel in accounting and financial reporting functions.
Sentiment
Score: 3
Explanation: The document presents a negative outlook due to significant losses, decreased sales, increased expenses, and a material weakness in internal control. The company's ability to continue as a going concern is uncertain.
Positives
- The company is addressing the material weakness in internal control by planning to hire additional personnel with technical expertise.
- Net cash provided by financing activities was $0.8 million due to increased borrowings from a stockholder.
Negatives
- The company experienced a significant decrease in product sales, impacting overall revenue.
- Operating expenses increased substantially, primarily due to stock compensation expenses.
- The company reported a substantial net loss and a significant accumulated deficit.
- The company identified a material weakness in internal control over financial reporting.
Risks
- The company's ability to continue as a going concern is subject to raising additional capital.
- The company faces risks related to economic conditions and competition within its industry.
- Failure to successfully develop business relationships could adversely affect the company's performance.
- The material weakness in internal control over financial reporting could lead to material misstatements in the financial statements.
Future Outlook
The company needs to raise additional capital to fund future operations and there is no assurance that any of this financing can be obtained or that the Company can continue as a going concern.
Management Comments
- Management believes that the hiring of additional personnel who have the technical expertise and knowledge with the non-routine or technical issues we have encountered in the past will result in both proper recording of these transactions and a much more knowledgeable finance department as a whole.
Industry Context
The company operates in the health and wellness industry, focusing on nutritional supplements and digital marketing services; the shift in marketing strategies reflects the dynamic nature of the e-commerce landscape and the need for continuous adaptation to maintain competitiveness.
Comparison to Industry Standards
- It is difficult to compare Limitless X Holdings to industry standards without specific competitor data.
- However, the significant decrease in revenue and increase in net loss suggest that the company is underperforming compared to industry averages.
- The company's reliance on related party transactions and the material weakness in internal control are also concerning compared to industry best practices.
- Comparable companies in the health and wellness e-commerce space include publicly traded firms like Nutrisystem and Herbalife, which have more robust financial performance and internal controls.
Related Party Transactions
- The company had royalty payables to companies owned by a shareholder.
- The company had notes payable to its shareholder and related parties, which were converted to preferred C and D shares.
- The company entered into a Loan Authorization and Agreement for a loan of $500,000 from a shareholder.
Stakeholder Impact
- Shareholders are negatively impacted by the significant net loss and the decrease in product sales.
- Employees may be affected by the company's financial difficulties and the need to raise additional capital.
- The material weakness in internal control over financial reporting raises concerns for all stakeholders.
Next Steps
- The company plans to hire additional personnel to address the material weakness in internal control over financial reporting.
- The company needs to secure additional financing to fund future operations.
Key Dates
| Date | Description |
|---|---|
| 2021-03-01 | Prime Time Live, Inc. received a $35,000 loan. |
| 2021-12-01 | Limitless Performance Inc. (LPI), SMILZ INC. (Smiles), DIVATRIM INC. (Divatrim), and AMAROSE INC. (Amarose, and collectively with LPI, Smiles, and Divatrim, the Licensors) are all companies at least 50% owned by a shareholder of the Company. On December 1, 2021, the Company entered into manufacturing and distributorship license agreements (each, a License Agreement) with each of the Licensors to distribute each of the Licensors respective products and for payments to such Licensor for its product designs and distribution rights. |
| 2022-05-11 | Bio Lab Naturals, Inc. entered into a Share Exchange Agreement with Limitless X, Inc. |
| 2022-05-20 | The LimitlessX Acquisition was completed and closed. |
| 2022-06-10 | Bio Lab changed its name to Limitless X Holdings Inc. |
| 2023-10-01 | The Company terminated each of the License Agreements; however, the Company maintained its license for NZT-48 with LPI. |
| 2024-12-31 | End of fiscal year 2024. |
| 2025-01-02 | Effective as of January 2, 2025, the Company filed a Certification of Designation of Class C Convertible Preferred Stock (the Certificate) with the Delaware Secretary of State and in accordance with the Delaware General Corporation Law. |
| 2025-01-23 | Effective as of January 23, 2025, the Company filed a Certificate of Designation of Series D 15 % Cumulative Redeemable Perpetual Preferred Stock (the Certificate) with the Delaware Secretary of State and in accordance with the Delaware General Corporation Law. |
| 2025-03-21 | The Company entered into a Loan Authorization and Agreement for a loan of $500,000 from a shareholder. |
| 2025-03-31 | End of Q1 2025. |
| 2025-04-10 | The Company issued 10,000 preferred C shares and 225,000 common stock shares under the Loan Authorization and Agreement. |
| 2025-05-06 | The Company issued 355,552 common shares to a consultant for consulting services. |
| 2025-05-18 | Date of the latest practicable date for shares outstanding. |
| 2025-05-21 | Date of report signature. |
Keywords
financial results, quarterly report, net loss, product sales, operating expenses, debt settlement, preferred stock, stock compensation, internal control, material weakness, related party transactions, going concern, Limitless X Holdings
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.